Outsourcing

Selecting and Optimizing the Right Manufacturing Partner

Optimizing the use of partners for clinical trials depends on selecting the right contractor.

Outsourcing's Race Toward Novelty

Recent outsourcing trends include early development services, biosimilar production, and RNA technology.

Preclinical Strategies Benefit Biopharma Development

Strategizing drug development in the preclinical phase has merit.

Balancing Internal Focus Against External Capabilities

May 19, 2022

Demand for outsourced services of technical R&D activities is increasing.

The Essential Ingredient in any Sponsor-CRO Partnership: Trust

May 16, 2022

To build trust and ensure a high-quality product, companies must be sure their contracts are firm and their lines of communication even firmer.

Fostering Orphan Drugs

May 15, 2022

CDMOs offer expertise and customization options for sponsors of orphan drugs.

Preparing for the Future: Expanding Capacity and Facilitating Multi-modalities

May 15, 2022

CDMOs need to consistently demonstrate agility as demand increases for newly developed therapeutic modalities.

The CDMO Carousel

May 15, 2022

Acquisitions in the CDMO space can give us insight into a company's vision for their future.

What Outsourcing Partners Wish You Knew

May 15, 2022

Industry experts share their top outsourcing tips from both the perspective of companies offering outsourcing services as well as for companies looking to outsource.

Converting Injectable Therapies to Combination Drug-Device Products

May 15, 2022

The author describes how to seize market opportunities while navigating the requirements of both drug therapies and delivery devices.

Scaling Up Cell Therapies Capacity

May 11, 2022

Outsourcing partners are ready to fill the market need for greater cell therapies capacities.

Addressing Limitations of Sterility Testing

May 01, 2022

Understanding both the challenges and solutions of aseptic manufacturing.

Using a Modeling Approach to Preclinical Studies

May 01, 2022

Applying modeling methods in preclinical studies can be a powerful tool for generating data and shortening development timelines.